The growth going forward for QCOR is ridiculous. They have only scratched the surface. Watch sales explode as they enter the Lupus market and when they announce they are going for the diabetes market, you will see a parabolic move. I urge you to listen to the last earnings conference call. It's an eye opener. Analysts are upgrading this stock left and right.